[
  {
    "question": "A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/\u03bcL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis?",
    "answer": "The most likely diagnosis in this case is Primary Central Nervous System Lymphoma (PCNSL). \n\nHere's the reasoning behind this conclusion:\n\n1. **Patient History and Symptoms**: The patient is a 58-year-old woman with HIV infection, which is a known risk factor for developing certain types of lymphomas, including PCNSL. Her symptoms of headaches, blurred vision, and confusion, along with neurological findings such as ataxia and memory impairment, suggest a central nervous system (CNS) pathology.\n\n2. **Immunocompromised State**: With a CD4+ T-lymphocyte count of 90/\u03bcL, the patient is immunocompromised, which increases the risk of opportunistic infections and malignancies, including lymphomas.\n\n3. **CSF Analysis**: The presence of lymphocytic predominant pleocytosis in the cerebrospinal fluid (CSF) is consistent with an inflammatory process or malignancy affecting the CNS.\n\n4. **PCR for Epstein-Barr Virus (EBV)**: The positive PCR for EBV DNA is significant because EBV is often associated with certain types of lymphomas, including PCNSL.\n\n5. **MRI Findings**: The MRI showing a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum is characteristic of PCNSL. Ring-enhancing lesions are often seen in primary brain tumors, and the location in the corpus callosum is consistent with PCNSL.\n\n6. **Differential Diagnosis**: While other conditions such as toxoplasmosis or other opportunistic infections could present with similar findings, the combination of the patient's immunocompromised status, specific MRI findings, and the presence of EBV DNA strongly supports the diagnosis of PCNSL.\n\nIn summary, the clinical presentation, laboratory findings, and imaging results collectively point towards a diagnosis of Primary Central Nervous System Lymphoma.",
    "true_answer": "The most likely diagnosis for a patient with HIV, presenting with neurological symptoms and a solitary ring-enhancing lesion, is primary cerebral lymphoma."
  },
  {
    "question": "A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein?",
    "answer": "The medication that acts on the gp41 subunit of the HIV envelope glycoprotein is called an entry inhibitor, specifically a fusion inhibitor. The most well-known fusion inhibitor is **Maraviroc** (Selzentry). This class of drugs prevents the HIV virus from entering and fusing with the host cells, thereby inhibiting the infection process.",
    "true_answer": "The medication that targets the gp41 subunit of the HIV envelope glycoprotein is enfuvirtide."
  },
  {
    "question": "A 27-year-old man presents with a 2-week history of fever, malaise, and occasional diarrhea. On physical examination, the physician notes enlarged inguinal lymph nodes. An HIV-1 detection test is positive. Laboratory studies show a CD4+ count of 650/mm3. This patient is most likely currently in what stage of HIV infection?",
    "answer": "The patient is most likely in the acute HIV infection stage, also known as primary HIV infection or acute retroviral syndrome. This stage typically occurs within the first few weeks after infection and is characterized by flu-like symptoms such as fever, malaise, and diarrhea. The presence of enlarged inguinal lymph nodes is also a common finding during this stage. The CD4+ count of 650/mm3 is within the normal range, which is consistent with the early stage of infection before significant immune system damage has occurred.",
    "true_answer": "This patient is most likely currently in the stage of acute HIV infection."
  },
  {
    "question": "A 50-year-old male with HIV presents to his primary care provider complaining of persistent fevers and night sweats over the past four months. He has also experienced a productive cough. He has been poorly adherent to his HAART regimen. His past medical history also includes gout, hypertension, and diabetes mellitus. He takes allopurinol, enalapril, and metformin. His temperature is 100.9\u00b0F (38.3\u00b0C), blood pressure is 125/75 mmHg, pulse is 95/min, and respirations are 20/min. His CD4 count is 85 cell/mm^3 and a PPD is negative. A chest radiograph reveals cavitations in the left upper lobe and left lower lobe. Bronchoalveolar lavage reveals the presence of partially acid-fast gram-positive branching rods. A head CT is negative for any intracranial process. What is the mechanism of action of the most appropriate drug for managing this patient\u2019s condition?",
    "answer": "The patient's symptoms, including persistent fevers, night sweats, productive cough, and the findings on chest radiograph (cavitations) along with the identification of partially acid-fast gram-positive branching rods in the bronchoalveolar lavage, strongly suggest a diagnosis of disseminated Mycobacterium avium complex (MAC) infection, which is a common opportunistic infection in patients with advanced HIV and low CD4 counts.\n\nThe most appropriate drug for managing this condition is typically a combination of antibiotics, often including clarithromycin, azithromycin, or rifabutin, along with ethambutol. Among these, clarithromycin is a commonly used antibiotic for treating MAC infections.\n\n**Mechanism of Action of Clarithromycin:**\nClarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis. It binds to the 50S ribosomal subunit of susceptible organisms, preventing the translocation step of aminoacyl transfer RNA and inhibiting peptide elongation. This ultimately leads to inhibition of protein synthesis and bacterial growth. Clarithromycin is effective against a variety of gram-positive bacteria, including Mycobacterium avium complex, making it a suitable choice for treating this patient's condition.",
    "true_answer": "The mechanism of action of the most appropriate drug to manage this patient's condition is inhibition of bacterial folic acid synthesis."
  },
  {
    "question": "A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing?",
    "answer": "The most likely target of the antibody the physician scientist is designing would be the HIV envelope glycoprotein, specifically gp120. This protein is a key component of the HIV envelope and is the primary target for neutralizing antibodies produced during the natural humoral immune response. Gp120 is responsible for binding to the CD4 receptor on host cells, which is a critical step in the viral entry process. Therefore, an antibody targeting gp120 could potentially block this interaction and prevent the virus from entering and infecting new cells, making it a highly relevant target for developing a more potent therapeutic antibody against HIV.",
    "true_answer": "The most likely target of the antibody being designed for HIV envelope proteins is gp120."
  },
  {
    "question": "A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism?",
    "answer": "The most likely causal organism in this case is **Aspergillus species**, specifically *Aspergillus fumigatus*. The presence of septate hyphae that branch at acute angles is characteristic of Aspergillus, and the clinical presentation of fever and hemoptysis in an immunocompromised patient (HIV-positive) with a fibrocavitary lesion on chest radiograph strongly suggests an aspergillus infection, particularly Aspergillus fumigatus.",
    "true_answer": "The most likely causal organism for the symptoms presented is Aspergillus fumigatus."
  },
  {
    "question": "A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3\u20134 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?",
    "answer": "Valganciclovir, an antiviral medication used to treat cytomegalovirus (CMV) infections, can lead to several adverse effects, particularly when added to an existing antiretroviral therapy regimen. The most significant adverse effects that the patient is at risk for include:\n\n1. **Hematologic Toxicity**: Valganciclovir can cause neutropenia (low neutrophil counts), anemia, and thrombocytopenia (low platelet counts). Given that the patient is already on antiretroviral therapy, which can also have hematologic side effects, the risk of these complications may be heightened.\n\n2. **Renal Toxicity**: Valganciclovir can cause nephrotoxicity, which may be exacerbated if the patient has pre-existing renal impairment or is taking other medications that affect kidney function.\n\n3. **Bone Marrow Suppression**: The combination of valganciclovir with other antiretroviral agents can increase the risk of bone marrow suppression, leading to a further decrease in white blood cell counts and an increased risk of infections.\n\n4. **Gastrointestinal Side Effects**: The patient may experience nausea, vomiting, or diarrhea, which could worsen his existing gastrointestinal symptoms.\n\n5. **Drug Interactions**: Valganciclovir can interact with other medications the patient is taking, potentially leading to increased toxicity or reduced efficacy of the drugs.\n\nMonitoring the patient closely for these adverse effects, particularly hematologic changes and renal function, will be essential during the course of treatment with valganciclovir.",
    "true_answer": "Treatment with valganciclovir places the patient at increased risk for pancytopenia."
  },
  {
    "question": "A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient\u2019s concern?",
    "answer": "The most appropriate diagnostic test to address the concern of HIV transmission to the baby would be to perform a **viral load test** on the newborn shortly after delivery. This test can detect the presence of HIV RNA in the baby's blood, providing a direct assessment of whether the virus has been transmitted. \n\nIn addition to the viral load test, it is also important to perform an **HIV antibody test** on the newborn, but this test may not be reliable in the first few weeks of life due to the presence of maternal antibodies. Therefore, the viral load test is the more immediate and reliable method for detecting HIV in the newborn. \n\nIt is crucial to initiate appropriate postnatal care and treatment for the mother and the newborn, including antiretroviral therapy (ART) for the mother during pregnancy and for the newborn after birth, to reduce the risk of transmission.",
    "true_answer": "The most appropriate test for early HIV diagnosis in a newborn is the polymerase chain reaction (PCR) for HIV RNA."
  },
  {
    "question": "A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?",
    "answer": "The most appropriate next step for the physician in this situation is to engage in a sensitive and ethical discussion with the patient regarding the implications of his diagnosis and the importance of disclosure to his wife. The physician should explain the following points:\n\n1. **Public Health Obligations**: The physician has a duty to protect public health and may be legally obligated to report certain infectious diseases, including HIV, to public health authorities. This is important for tracking and preventing the spread of the disease.\n\n2. **Importance of Disclosure**: The physician should emphasize the importance of informing his wife about the diagnosis, as she may be at risk of exposure. This is crucial for her health and well-being, as she may need to be tested and potentially receive treatment or counseling.\n\n3. **Support and Resources**: The physician should offer support and resources for the patient to help him navigate this difficult situation. This could include counseling services, support groups, or information on how to disclose the diagnosis to his wife in a sensitive manner.\n\n4. **Confidentiality**: While respecting the patient's confidentiality, the physician should explain that there are limits to confidentiality when it comes to serious health risks to others. The physician should encourage open communication between the patient and his wife.\n\n5. **Next Steps**: The physician should discuss the next steps in managing the patient's HIV, including further testing, treatment options, and the importance of regular follow-up.\n\nUltimately, the physician should encourage the patient to consider the well-being of his wife and the broader implications of nondisclosure, while also respecting his concerns and providing support throughout this process.",
    "true_answer": "The physician should report the HIV infection to the national health authorities while maintaining confidentiality per regulations."
  },
  {
    "question": "A 41-year-old woman presents with acute onset severe epigastric pain radiating to the back that began a few hours ago. She also complains of nausea and has vomited twice in the past hour. She denies any history of similar symptoms or trauma in the past. Past medical history is significant for diabetes type 2 and HIV infection diagnosed 6 months ago long-standing mild intermittent asthma, and generalized anxiety disorder. She takes metformin for her diabetes but does not remember the names of her HIV medications. She reports moderate social alcohol use. Her vital signs include temperature 37.6\u00b0C (99.6 \u00b0F), pulse 95/min, blood pressure 110/74 mm Hg, respiratory rate 12/min Her body mass index (BMI) is 21 kg/m2. Laboratory findings are significant for the following: Serum amylase: 415 U/L, Serum lipase: 520 U/L. A contrast CT of the abdomen reveals an edematous pancreas with peripancreatic fluid collection with a normal gallbladder. What is the most likely etiology of this patient\u2019s condition?",
    "answer": "The most likely etiology of the patient's condition is acute pancreatitis. The symptoms of severe epigastric pain radiating to the back, nausea, and vomiting, along with the elevated serum amylase and lipase levels, are consistent with this diagnosis. The presence of an edematous pancreas and peripancreatic fluid collection on the CT scan further supports this diagnosis. Given her history of diabetes and alcohol use, these factors could contribute to the development of acute pancreatitis.",
    "true_answer": "It is most likely related to their HIV medication."
  },
  {
    "question": " A 28-year-old primigravid woman at 38 weeks' gestation is brought to the emergency department in active labor. She has not had regular prenatal care. She has a history of HIV infection but is not currently on antiretroviral therapy. Her previous viral load is unknown. Treatment with intravenous zidovudine is begun to reduce perinatal transmission of the virus. What biological process is most likely disrupted by this drug\u2019s action mechanism?",
    "answer": "Zidovudine, also known as AZT, is a nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV infection. Its primary mechanism of action is to inhibit the enzyme reverse transcriptase, which is crucial for the replication of the HIV virus. Reverse transcriptase is responsible for converting the viral RNA into DNA, a necessary step for the virus to integrate its genetic material into the host cell's DNA.\n\nBy disrupting this process, zidovudine effectively prevents the HIV virus from replicating and spreading within the host. This reduction in viral replication is essential in managing HIV infection and, in the context of pregnancy, helps to lower the risk of perinatal transmission of the virus from mother to child. Therefore, the biological process most likely disrupted by zidovudine's action mechanism is the reverse transcription of viral RNA into DNA, which is a critical step in the HIV life cycle.",
    "true_answer": " Zidovudine affects elongation of viral DNA by inhibiting the viral reverse transcriptase enzyme."
  },
  {
    "question": "What is known about DNA methylation profiles in patients with latent HIV-1 or with an active infection?",
    "answer": "In patients with latent HIV-1, DNA methylation profiles are associated with transcriptional silencing of the provirus. In contrast, patients with active HIV-1 infection exhibit DNA methylation profiles that are associated with transcriptional activation of the provirus.",
    "true_answer": "DNA methylation is correlated with and functionally linked to HIV-1 pathogenesis and latency. In active infection, HIV-1 infection is associated with global changes in host cell DNA methylation patterns, while in latent infection, methylation of the proviral DNA, particularly in the 5\u2019 LTR promoter and intragenic regions, plays a crucial role in maintaining viral latency."
  }
]